Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome - Wikidata - wikimedia - TriplyDB

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

http://www.wikidata.org/entity/Q35362266

about

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes Role for protease activity in visceral pain in irritable bowel syndrome Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity Enteroendocrine cells: neglected players in gastrointestinal disorders?An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial Dietary triggers in irritable bowel syndrome: Is there a role for gluten Inflammation in irritable bowel syndrome: Myth or new treatment target?Gut microbiota role in irritable bowel syndrome: New therapeutic strategies Diet in irritable bowel syndrome Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea Brain-gut axis: from basic understanding to treatment of IBS and related disorders Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome Gut microbiota as potential orchestrators of irritable bowel syndrome Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine Management of the returning traveler with diarrhea Bibliometric analysis of publications on Campylobacter: (2000-2015)Can probiotics modulate human disease by impacting intestinal barrier function?Factors Associated with Sequelae of Campylobacter and Non-typhoidal Salmonella Infections: A Systematic Review.Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction New pathophysiological mechanisms in irritable bowel syndrome.Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).IBS and the role of otilonium bromide.A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.Importance of early diagnosis in patients with irritable bowel syndrome.Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study.Involvement of interleukin-17A-induced hypercontractility of intestinal smooth muscle cells in persistent gut motor dysfunction Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion.Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.The role of peptide YY in gastrointestinal diseases and disorders (review).Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome Immune activation and gut microbes in irritable bowel syndrome.Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance

P2860

Q21261902-30DC6B1A-5E9C-4EFC-9792-88A62451B9CD Q22241892-65E25014-BB42-4A6E-9627-63AAB61B7772 Q24623796-2A51BFA7-4E08-4D5C-8D49-E4F7D0DF72EA Q24629026-1E8D60B4-3D2E-418E-AEC3-05A3E5F2831F Q24630575-81E2CA13-F177-4A4C-A76F-357BD0CADA0E Q24658463-4932583A-204A-4D66-9E9A-57F832ED8A02 Q24685836-0BBFEDA3-AD34-4818-9AD7-F68973F661D7 Q26739974-11B14418-E00B-472D-ABC9-783EDDF762EF Q26768545-95F8EDDD-D396-4EAC-A8B8-BC2EFD64E817 Q26768550-3DDD1A13-8389-4805-B6EA-1BC6DE50BE51 Q26824367-851C8A0F-B6FB-4CD0-A629-65483F11937C Q26828617-7B5AD2A4-D8DB-408A-82E2-C4970F3A7B1B Q26830683-F2A67913-7440-4AE4-8970-9E3495CBD1EA Q26853285-BDB10E75-732E-43E6-8679-962EE8E8E83F Q27024801-9B570075-13F6-4CD5-8E94-B4815F34AAE0 Q28072085-A4E06A32-D5EA-4651-A3D6-5C5AC8012C4F Q28085584-BB60373A-F3BB-48A0-8EB3-580D312C0ED7 Q28287402-C58EA3C2-5263-4326-B01C-C60612ACBADE Q28385300-46FBCACE-D736-4F9C-83E0-0B44E4CC9CF5 Q28554580-0BF5159B-3B58-4F73-BC18-CC94040F46F7 Q28817192-2AA90DF5-477B-4668-A2FA-D712AD6E46A8 Q30240066-1E449C6B-20B9-47B9-BEF0-A3E0AB104451 Q30447974-717898DF-20E1-4B7E-AF3F-C4BC24EA7D75 Q30489893-018A1A4B-8B67-46AE-A31D-B53E80E3AE9A Q33432064-0F00FD22-C38D-4B85-989A-0418E016B577 Q33452388-0783C05E-6524-40FE-9E64-2CC79D56687D Q33456428-A5F561E2-D0FC-4EC3-823B-08F2B10EA946 Q33470900-2D3067D9-44D4-4A4E-B4D8-F69D17380620 Q33536973-C5012CC9-E742-47C6-AB30-4381430018B4 Q33565207-FFA011FD-EB07-4785-ADD3-38DC4B22162D Q33567657-B4A7138E-BAAB-4D99-A719-5E1803764EE6 Q33575746-24D1D0E5-1D78-40ED-BB81-EB9D871387F5 Q33618369-F6EC12D9-CCBC-4EDD-AB41-79E9ECB62F51 Q33625633-849E8CCC-C10B-4012-AF85-76AF84BE6DFB Q33672837-F9353754-334D-4E5C-A94A-2665FA9299F1 Q33703912-10B11A87-1534-462E-A15C-69D196C0506C Q33784540-C2BA4688-3C34-4A78-AFE6-3E6A980BCFA1 Q33855474-C7EAD169-1DBA-4FBF-A9D3-B6D5223E78B2 Q33890449-AD750FFF-75BF-4419-ADC6-A665035E75C8 Q33926234-AF6FFBCD-E973-4483-803A-861D600D1CB8

P2860

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

http://www.wikidata.org/entity/Q35362266

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@ast

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@en

type

label

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@ast

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@en

prefLabel

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@ast

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@en

P1433

Q35362266-3485FBBA-B063-42B7-9D08-AFBAA778C176

P1476

Q35362266-59A88DBD-9513-488F-A3BA-FDB75AB3F762

P2093

Q35362266-01895DB8-F1B1-4386-986A-D9341DA1EF73

Q35362266-4889623C-667E-4381-AD88-5C850410B55B

Q35362266-608A5AD2-15AA-42C5-B426-DA63D0D44492

Q35362266-ACF6CF35-4AEA-4E27-AC6A-BE55C2E20E7C

Q35362266-CFF44211-FBDF-476E-8F1F-11F3EDC812C2

Q35362266-D24D90E6-13C9-496F-94A4-EF5BDB191D97

Q35362266-E2F724C2-CA58-4CDE-A134-83DAD34E809E

P2860

Q35362266-0BD4E667-3C2A-44C6-857A-136B57FFA304

Q35362266-0E2CA370-F24C-42DA-9B4C-645AC41CE3C4

Q35362266-1511B6A6-3B20-4A6D-AF73-EA784651582E

Q35362266-1709D504-6546-49C6-943E-5B0147F5E7DB

Q35362266-1D162D3B-D804-47AA-BD9D-C11B7BBA9929

Q35362266-1D6F33FD-45B9-4B16-86CA-75B9CB344943

Q35362266-2B818123-FA98-40C0-98BB-E17C245417DC

Q35362266-2BE42C4E-4588-41CB-BCF7-63513CC25674

Q35362266-2BFC12D2-B990-4487-A375-4EE61A449701

Q35362266-30116A9C-A8B7-4B4D-87B3-1B7F88570C01

P304

Q35362266-589596B7-C950-4A7A-A271-1F06A9CFD930

P31

Q35362266-376105E0-B28A-4991-8D7B-017D68E6BB50

P356

Q35362266-0103D93A-776F-4F9F-BB01-8A4EC9413ADA

P407

Q35362266-8F1D8999-BBA4-4D9F-93E0-9D0C5E22B860

P433

Q35362266-A1AD79A5-ABF0-4220-BAEF-275EEC2D3AD8

P478

Q35362266-240E25D8-1C2C-494D-A50A-4370EBBC557B

P577

Q35362266-564F539F-251E-4061-B88F-1C9AB1C4F313

P5875

Q35362266-5756541C-CA76-479D-A889-904BF9D454E2

P698

Q35362266-D0CA7906-422A-44FD-88BA-474ECB8B0422

P921

Q35362266-80C20A21-D227-46D8-BFFE-08AF16F19821

P932

Q35362266-125D8651-00E0-46C2-94E5-AC41B36C5DBA

P356

P1433

P1476

Increased rectal mucosal enter ...... teric irritable bowel syndrome

@en

P2093

Hebden JM

http://www.w3.org/2001/XMLSchema#string

Jenkins D

http://www.w3.org/2001/XMLSchema#string

Neal KR

http://www.w3.org/2001/XMLSchema#string

Skinner M

http://www.w3.org/2001/XMLSchema#string

Spiller RC

http://www.w3.org/2001/XMLSchema#string

Thornley JP

http://www.w3.org/2001/XMLSchema#string

Wright T

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis

Human distribution and release of a putative new gut hormone, peptide YY

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56lck.

Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

Enteropathy of coeliac disease in adults: increased number of enterochromaffin cells the duodenal mucosa.

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

Intestinal permeability in children with Crohn's disease and coeliac disease.

P304

804-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.47.6.804

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277418932

http://www.w3.org/2001/XMLSchema#string

P698

11076879

http://www.w3.org/2001/XMLSchema#string

P921

P932

1728147

http://www.w3.org/2001/XMLSchema#string